1. nashville30
2. arizonaatv
3. 476waltercharles
4. dadtwomany
1.476waltercharles 02/26/2018
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease
2.dadtwomany 05/10/2018
4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018
3.476waltercharles 06/04/2018
Presents long-term safety and efficacy data for Xyrem
4.nashville30 06/28/2018
Jazz Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients
5.dadtwomany 05/10/2018
Agrees to pay $57M to DOJ to settle inquiry into Medicare patient assistance activities
6.nashville30 05/01/2018
Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients
7.arizonaatv 02/28/2018
BMO Capital raises PT to $199 from $196
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW